pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
  • phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07278466: The COMParing App Support Strategies Study

    Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Depression, Anxiety

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07512466: Evaluation of Endoscopic Management of Sinonasal Tumors In Difficult Anatomical Locations

    Sponsor: Assiut University. Phase: NA. Conditions: Nasal Cavity and Paranasal Sinus Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06172166: Transdisciplinary Care for Young Adults With Type 1 Diabetes

    Sponsor: Nemours Children's Clinic. Phase: NA. Conditions: Type 1 Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05744856: A Co-created Self-care and Informal Support Intervention Study Among Women With GDM in Vietnam

    Sponsor: Thai Binh University of Medicine and Pharmacy. Phase: NA. Conditions: GDM

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04647422: Social Cognition and Executive Functions in Alcohol Use Disorders - Transverse Study

    Sponsor: CHU de Reims. Phase: NA. Conditions: Alcohol Use Disorder

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07589751: Biomaterials Exposed to Oral Environment: Which One is the Appropriate Option?

    Sponsor: Pontificia Universidade Católica do Rio Grande do Sul. Phase: NA. Conditions: Tooth Extraction Site Healing, Alveolar Ridge Preservation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07517029: Gut Microbiome in Patients With Post-infectious Irritable Bowel Syndrome

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: IBS - Irritable Bowel Syndrome, Post Infection Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05966129: A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Acute Pain Trial)

    Sponsor: Duke University. Phase: NA. Conditions: Acute Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07196631: Comparison of Liposomal Bupivacaine Versus Ropivacaine in Alleviating Rebound Pain

    Sponsor: Liu Jiuhong. Phase: PHASE4. Conditions: Rebound Pain, Liposomal Bupivacaine

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07255937: PMCF Study of Debridement Pad

    Sponsor: Advanced Medical Solutions Ltd.. Phase: NA. Conditions: Diabetic Ulcers, Venous Leg Ulcer, Arterial Leg Ulcer, Pressure Ulcer, Postoperative Wound Healing, Traumatic Wounds, Surgical Wounds, Burns and Scalds

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT04973345: Terbutaline Sulfate in Adults With Asthma

    Sponsor: Kanecia Obie Zimmerman. Phase: PHASE2. Conditions: Asthma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07326072: The Study of ENB With Ultra-thin Cryobiopsy in the Diagnosis of Peripheral Pulmonary Nodules

    Sponsor: Beijing Chao Yang Hospital. Phase: NA. Conditions: Diagnosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05353257: A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer

    Sponsor: Shanghai Henlius Biotech. Phase: PHASE3. Conditions: Limited-Stage Small Cell Lung Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07547657: Implementation Guided by aN Iterative, adapTivE Strategy - Induction of Labor

    Sponsor: University of Michigan. Phase: NA. Conditions: Birth; Induced

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06280157: A Follow up Study of Group B Streptococcus (GBS)-NN/NN2 Vaccine in Healthy Volunteers

    Sponsor: Minervax ApS. Phase: . Conditions: Group B Streptococcus Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07691801: Study on the Application of Liquid Chromatography-Tandem Mass Spectrometry for the Determination of Aldosterone and Renin Activity in the Diagnosis of Primary Aldosteronism by Captopril Test

    Sponsor: Peking Union Medical College Hospital. Phase: . Conditions: Primary Aldosteronism

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06307301: Study in ALS With Abatacept & IL-2

    Sponsor: The Methodist Hospital Research Institute. Phase: PHASE1. Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT07219381: Holistic Medicine Treatment of Uterine Fibroids-Adults

    Sponsor: Virtual Tribunal Monastery. Phase: NA. Conditions: Uterine Fibroids - 1St Diagnosis, Uterine Fibroids Affecting Pregnancy, Uterine Fibroid Degenerated

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04498481: TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

    Sponsor: Pfizer. Phase: . Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07527481: Nortriptyline and the Risk of Serious Adverse Events

    Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. Phase: . Conditions: Chronic Kidney Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05934019: Efficacy of a Transdiagnostic Online Prevention Approach in Adolescents (EMPATIA)

    Sponsor: University of Bern. Phase: NA. Conditions: Mental Health Issue, Transdiagnostic Mechanisms, Adolescent Psychology, Prevention, Online Intervention, Psychological Intervention, Mental Disorder in Adolescence, Subclinical

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07456319: Sustainable Insect-based Protein Supplement in the Elderly: a Pilot Study

    Sponsor: Universitat Oberta de Catalunya. Phase: NA. Conditions: Aging, Nutrition, Sustainable Diets, Cardiometabolic Health

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05363319: An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe

    Sponsor: Regeneron Pharmaceuticals. Phase: . Conditions: Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07380230: Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients

    Sponsor: LI FENG. Phase: NA. Conditions: Acute Radiation Dermatitis, Traditional Chinese Medicine (TCM), Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07321730: Surgeons' Ability to Predict Pathological and Molecular Features of Peritoneal Carcinomatosis in Ovarian Cancer

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Ovarian Cancer

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT06806228: Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)

    Sponsor: Petrov, Andrey. Phase: PHASE1. Conditions: Glioblastoma Multiforme, Diffuse Midline Glioma, H3 K27M-Mutant, Gliosarcoma, Giant Cell Glioblastoma, GBM

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04699630: A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

    Sponsor: SCRI Development Innovations, LLC. Phase: PHASE2. Conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07493928: HPV After chemoRadioTherapy

    Sponsor: General University Hospital, Prague. Phase: . Conditions: Cervical Cancer Recurrent, Radiotherapy, Cell Free DNA, HPV

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00898365: Study of Kidney Tumors in Younger Patients

    Sponsor: Children's Oncology Group. Phase: . Conditions: Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor, Angiolipoma, Cellular Congenital Mesoblastic Nephroma, Classic Congenital Mesoblastic Nephroma, Clear Cell Sarcoma of the Kidney, Congenital Mesoblastic Nephroma, Cystic Partially Differentiated Kidney Nephroblastoma, Diffuse Hyperplastic Perilobar Nephroblastomatosis, Extrarenal Rhabdoid Tumor, Kidney Medullary Carcinoma, Kidney Neoplasm, Kidney Oncocytoma, Kidney Wilms Tumor, Metanephric Adenofibroma, Metanephric Adenoma, Metanephric Stromal Tumor, Metanephric Tumor, Mixed Congenital Mesoblastic Nephroma, Ossifying Renal Tumor of Infancy, Papillary Renal Cell Carcinoma, Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Rhabdoid Tumor of the Kidney, Wilms Tumor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00156767: Adrenal Function in Critical Illness

    Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Adrenal Insufficiency

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07393867: Androgen-responsive POSLUMA-guided Intra-prostatic Boost

    Sponsor: Martin T. King, MD, PhD. Phase: PHASE2. Conditions: Intermediate Risk Prostate Cancer, High Risk Prostate Cancer, Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07499765: Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis

    Sponsor: Centre Henri Becquerel. Phase: NA. Conditions: Acute Leukemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03635567: Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Cervical Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05464667: Preoperative Irradiation for Stage I Breast Cancer

    Sponsor: Parul Barry. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07646600: Observational Study of Natural History of BAG3 Gene Mutation-Associated Dilated Cardiomyopathy in Chinese Adults

    Sponsor: AstraZeneca. Phase: . Conditions: Dilated Cardiomyopathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01587300: Neuroblastoma Biology Study

    Sponsor: New Approaches to Neuroblastoma Therapy Consortium. Phase: . Conditions: Neuroblastoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06004882: Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot Study

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Peripheral Nerve Stimulation, Genicular Nerves, Chronic Knee Pain

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07543224: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.

    Sponsor: Reistone Biopharma Company Limited. Phase: PHASE3. Conditions: Plaque Psoriasis Subjects

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01386424: Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Zika, Influenza

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01296724: PREMAPIV : Intravesical Pressure Variation at Different Bladder Instillation Volumes in Newborn Children

    Sponsor: Rennes University Hospital. Phase: NA. Conditions: Intensive Care Unit Syndrome

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04363580: Creation of Auditory Processing Disorder Screening Tool in French

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Auditory Processing Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04232280: Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults

    Sponsor: ModernaTX, Inc.. Phase: PHASE2. Conditions: Cytomegalovirus Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07227896: Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease

    Sponsor: AbbVie. Phase: . Conditions: Parkinson's Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07672496: Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection

    Sponsor: Fujian Medical University Union Hospital. Phase: NA. Conditions: Complicated Intra-abdominal Infection (cIAI), Systemic Inflammatory Response, Sepsis, Immune Dysfunction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07007546: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants

    Sponsor: Abbisko Therapeutics Co, Ltd. Phase: PHASE1. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06997588: EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE2. Conditions: PIK3CA-related Overgrowth Spectrum (PROS)

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07197788: Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

    Sponsor: Endogenex, Inc.. Phase: NA. Conditions: Type 2 Diabetes Mellitus, Type2diabetes, Diabetes Mellitus, Type 2, Type 2 Diabetes, Diabetes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07496203: The Effectiveness of BETY in Knee Osteoarthritis With Intra-Articular Injections

    Sponsor: Hacettepe University. Phase: NA. Conditions: Osteo Arthritis of the Knee, Pain, Pain Management, Exercise

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07598942: Gingival TrxR1 Expression in Periodontal Health and Periodontitis

    Sponsor: Ataturk University. Phase: . Conditions: Periodontitis, Oxidative Stress

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04631042: Developing Brain, Impulsivity and Compulsivity

    Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Typical Development, Obsessive Compulsive Disorder, Conduct Disorder, Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder

    full page →ctgov ↗
    ← prev
    page 82 of 104
    next →